The FDA introduced new generic drug approval rules between 2023 and 2025 to boost domestic manufacturing. Learn how the ANDA Prioritization Pilot impacts prices, shortages, and drug safety.
Two new congressional bills aim to fix drug and healthcare provider shortages, but both are stalled by a historic government shutdown. Without action before January 2026, they’ll die-and the crisis will keep getting worse.